[Suppression of non-small-cell lung carcinoma metastasis with clarithromycin].
Sakamoto
M
M
Mikasa
K
K
Majima
T
T
Hamada
K
K
Konishi
M
M
Yoshimoto
E
E
Takahashi
S
S
Narita
N
N
Maeda
K
K
Murakawa
K
K
Kita
E
E
D000368:Aged; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001932:Brain Neoplasms / Q000188:drug therapy / Q000556:secondary; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000556:secondary*; D017291:Clarithromycin / Q000627:therapeutic use*; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007155:Immunologic Factors; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008875:Middle Aged; D012189:Retrospective Studies
D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D017291:Clarithromycin